Ultravalue Pharmaceuticals Private Limited
Pharmaceutical trading company based in Uttar Pradesh, established in 2022.
2022 | Lucknow, Uttar Pradesh (India) | Active
Ultravalue Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 3 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
About Ultravalue Pharmaceuticals
Ultravalue Pharmaceuticals Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 June 2022 (Three years 2 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Corporate was formerly known as Puralma Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Singh, Rakesh Kumar, Purshottam Bajpai, and Two other members serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51900UP2022PTC165514
- Company No.
165514
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 2022
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Pharma
Ultravalue Pharmaceuticals Private Limited
Explore comprehensive data for Ultravalue Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Ultravalue Pharmaceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Singh  | Director | 10-Jun-2022 | Current |
| Rakesh Kumar | Director | 10-Jun-2022 | Current |
| Purshottam Bajpai | Director | 10-Jun-2022 | Current |
| Lalan Singh | Director | 10-Jun-2022 | Current |
| Amit Anit | Director | 10-Jun-2022 | Current |
Financial Performance of Ultravalue Pharmaceuticals.
Ultravalue Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ultravalue Pharmaceuticals?
Unlock access to Ultravalue Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Value Formulations Private Limited
Purshottam Bajpai is a mutual person
- Valuemoney Nidhi Limited
Purshottam Bajpai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ultravalue Pharmaceuticals?
Ultravalue Pharmaceuticals has a workforce of 75 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ultravalue Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultravalue Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Ultravalue Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Ultravalue Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2023 as per latest MCA records.
- Balance Sheet
Ultravalue Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur.
- Director Appointment
Mahesh Prasad Singh was appointed as a Director was appointed as a Director on 10 Jun 2022 & has been associated with this company since 3 years 2 days .
- Director Appointment
Rakesh Kumar was appointed as a Director was appointed as a Director on 10 Jun 2022 & has been associated with this company since 3 years 2 days .
- Director Appointment
Purshottam Kant Bajpai was appointed as a Director was appointed as a Director on 10 Jun 2022 & has been associated with this company since 3 years 2 days .
- Director Appointment
Lalan Singh was appointed as a Director was appointed as a Director on 10 Jun 2022 & has been associated with this company since 3 years 2 days .
Frequently asked questions
What is the Incorporation or founding date of Ultravalue Pharmaceuticals Private Limited?
Ultravalue Pharmaceuticals Private Limited was incorporated on 10 Jun 2022.
What is authorized share capital and paid-up capital of Ultravalue Pharmaceuticals Private Limited?
The authorized share capital of Ultravalue Pharmaceuticals Private Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.
Who are the current board members & directors of Ultravalue Pharmaceuticals Private Limited?
Currently 5 directors are associated with Ultravalue Pharmaceuticals Private Limited.
- Mahesh Prasad Singh
- Rakesh Kumar
- Purshottam Kant Bajpai
- Lalan Singh
- Amit Kumar Anit
What is the registered address of Ultravalue Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Ultravalue Pharmaceuticals Private Limited is Basement 26/11, Radiant Apartment Wazir Hasan Road India, Lucknow, Uttar Pradesh, 226001.
What is the corporate identification number (CIN) and company number of Ultravalue Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Ultravalue Pharmaceuticals Private Limited is U51900UP2022PTC165514 and the company number is 165514 as per Ministry of Corporate Affairs (MCA).
How many employees does Ultravalue Pharmaceuticals Private Limited currently have?
As Per 2023 financial reports, 75 employees are currently employed by Ultravalue Pharmaceuticals Private Limited.
When was the last Balance Sheet of Ultravalue Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Ultravalue Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records